P19-44. Priming with a DNA vaccine enconding HIV CD4+ T cell epitopes enhances responses against subsequent immunization with plasmid encoding Vif

Retrovirology, Oct 2009

SP Ribeiro, RR Almeida, DS Rosa, EG Kallás, J Kalil, E Cunha-Neto

Article PDF cannot be displayed. You can download it here:

http://www.retrovirology.com/content/pdf/1742-4690-6-S3-P364.pdf

P19-44. Priming with a DNA vaccine enconding HIV CD4+ T cell epitopes enhances responses against subsequent immunization with plasmid encoding Vif

Retrovirology Poster presentation P19-44. Priming with a DNA vaccine enconding HIV CD4+ T cell epitopes enhances responses against subsequent immunization with plasmid encoding Vif SP Ribeiro 0 RR Almeida 0 DS Rosa 0 EG Kalls 0 J Kalil 0 E Cunha-Neto 0 0 Address: Clinical Immunology and Allergy, University of So Paulo , So Paulo , Brazil - Background Since none of the developed candidate vaccines against HIV has been effective, novel vaccine concepts are needed. Our group has identified conserved HIV CD4+ T cell epitopes binding promiscuously to multiple HLA-DR molecules, and frequently recognized by HIV-1-infected patients. A DNA vaccine encoding such epitopes (pVAXHIVBr18) showed strong cellular responses in mice. An early CD8+ T cell response against Vif is associated with control of SIV infection in primates. A vaccine capable of stimulating both CD4+ and CD8+ T cells can be useful to establish an appropriate immune control of HIV. We aim to test whether preimmunization with pVAX-HIVBr18, which contains the CD4/CD8 Vif (144-158) epitope, can boost Vif-specific CD8+ T cell responses after immunization with a plasmid encoding Vif (pVAX-Vif). Methods Synthetic genes encoding either 18 HIV-1 CD4+ T cell epitopes or HIV-1 Vif were subcloned in the pVAX vector to obtain pVAX-HIVBr18 and pVAX-vif. BALB/c mice were immunized with pVAX-vif (3 doses) or preimmunized with pVAX-HIVBr18 before receiving pVAX-vif (2 doses) every 2 weeks. T cell responses were assessed by IFNgamma ELISPOT, Cytometric Bead Array, intracellular cytokine staining and CFSE based proliferation assay. Results Immunization with pVAX-vif induced proliferation of CD4+ and CD8+ T cells against different pooled Vif peptides. Preimmunization with pVAX-HIVBr18 enhanced the magnitude and breadth of the proliferative response of central and effector memory CD4+ and CD8+ T cells against Vif peptide pool 9, containing the homologous peptide, and, surprisingly, to Vif pools 2, 3 and 7, which did not contain the epitope. Moreover, preimmunization with pVAX-HIVBr18 also increased the number of CD4+ and CD8+ T cells producing TNF- and IFN-gamma. Conclusion Our data suggest that preimmunization with a plasmid encoding CD4+ T cell epitopes induces proliferative and cytokine responses of CD4+ and CD8+ T cells to multiple Vif peptide pools, suggesting an epitope spreading mechanism. (...truncated)


This is a preview of a remote PDF: http://www.retrovirology.com/content/pdf/1742-4690-6-S3-P364.pdf
Article home page: http://www.retrovirology.com/content/6/S3/P364

SP Ribeiro, RR Almeida, DS Rosa, EG Kallás, J Kalil, E Cunha-Neto. P19-44. Priming with a DNA vaccine enconding HIV CD4+ T cell epitopes enhances responses against subsequent immunization with plasmid encoding Vif, Retrovirology, 2009, pp. P364, 6,